Benzinga's Top Upgrades, Downgrades For February 1, 2018

Top Upgrades

  • Bank of America upgraded Qorvo Inc QRVO from Underperform to Neutral. Qorvo shares rose 12.19 percent to $80.52 in pre-market trading.
  • Gabelli & Co. upgraded Dr Pepper Snapple Group Inc. DPS from Hold to Buy. Dr Pepper Snapple shares rose 0.29 percent to close at $119.35 on Wednesday.
  • Argus upgraded Advanced Micro Devices, Inc. AMD from Hold to Buy. AMD rose 0.73 percent to $13.84 in pre-market trading.
  • Morgan Stanley upgraded Textron Inc TXT from Underweight to Equal-Weight. Textron shares dropped 2.51 percent to close at $58.67 on Wednesday.
  • Analysts at Loop Capital upgraded CACI International Inc CACI from Hold to Buy. CACI International shares slipped 0.07 percent to close at $140.55 on Wednesday.
  • Analysts at RBC Capital upgraded eBay Inc EBAY from Sector Perform to Outperform. eBay shares rose 10.40 percent to $44.80 in pre-market trading.
  • Keefe Bruyette & Woods upgraded Centerstate Bank Corp CSFL from Market Perform to Outperform. CenterState Bank shares rose 0.43 percent to close at $25.99 on Wednesday.
  • Analysts at PiperJaffray upgraded Veritex Holdings Inc VBTX from Neutral to Overweight. Veritex shares fell 0.38 percent to close at $28.51 on Wednesday.
  • Credit Suisse upgraded Invesco Ltd. IVZ from Neutral to Outperform. Invesco shares fell 1.50 percent to close at $36.13 on Wednesday.
  • JP Morgan upgraded Canadian Solar Inc. CSIQ from Underweight to Neutral. Canadian Solar shares rose 1.56 percent to $15.65 in pre-market trading.

Top Downgrades

  • JMP Securities downgraded Emerson Electric Co. EMR from Market Outperform to Market Perform. Emerson Electric shares fell 0.33 percent to close at $72.23 on Wednesday.
  • Bernstein downgraded Express Scripts Holding Company ESRX from Market Perform to Underperform. Express Scripts shares fell 1.20 percent to $78.23 in pre-market trading.
  • Mizuho downgraded Starbucks Corporation SBUX from Buy to Neutral. Starbucks shares dropped 0.24 percent to $56.67 in pre-market trading.
  • Analysts at UBS downgraded Chipotle Mexican Grill, Inc. CMG from Neutral to Sell. Chipotle fell 2.54 percent to $316.50 in pre-market trading.
  • RBC Capital downgraded KapStone Paper and Packaging Corp. KS from Outperform to Sector Perform. KapStone Paper shares rose 0.14 percent to close at $34.64 on Wednesday.
  • Leerink Swann downgraded NuVasive, Inc. NUVA from Outperform to Market Perform. NuVasive shares fell 1.78 percent to $48.00 in pre-market trading.
  • Barclays downgraded TCF Financial Corporation TCF from Overweight to Equal-Weight. TCF Financial shares fell 0.65 percent to close at $21.45 on Wednesday.
  • Analysts at JP Morgan downgraded Avery Dennison Corp AVY from Neutral to Underweight. Avery Dennison shares rose 4.56 percent to close at $122.68 on Wednesday.
  • Wells Fargo downgraded Check Point Software Technologies Ltd. CHKP from Outperform to Market Perform. Check Point shares fell 0.83 percent to $102.55 in pre-market trading.

Top Initiations

  • Analysts at Bernstein initiated coverage on Concho Resources Inc CXO with an Outperform rating. The price target for Concho Resources is set to $187. Concho Resources shares closed at $157.44 on Wednesday.
  • Morgan Stanley initiated coverage on Take-Two Interactive Software Inc TTWO with an Overweight rating. The price target for Take-Two is set to $150. Take-Two shares closed at $126.67 on Wednesday.
  • Jefferies initiated coverage on Cross Country Healthcare, Inc. CCRN with a Hold rating. The price target for Cross Country Healthcare is set to $15. Cross Country Healthcare shares closed at $14.01 on Wednesday.
  • Analysts at Berenberg initiated coverage on Perrigo Company plc PRGO with a Buy rating. The price target for Perrigo is set to $117. Perrigo shares closed at $90.62 on Wednesday.
  • Jefferies initiated coverage on AMN Healthcare Services, Inc. AMN with a Buy rating. The price target for AMN Healthcare is set to $66. AMN Healthcare shares closed at $53.65 on Wednesday.
  • Berenberg initiated coverage on Supernus Pharmaceuticals Inc SUPN with a Buy rating. The price target for Supernus Pharmaceuticals is set to $66. Supernus Pharmaceuticals shares closed at $39.05 on Wednesday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesDowngradesInitiationPre-Market OutlookAnalyst RatingsInitiationstop upgrades
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!